Edgardo S Fortuno 3rd
Overview
Explore the profile of Edgardo S Fortuno 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
760
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dev R, Fortuno 3rd E, Amaram-Davila J, Haider A, Bruera E
Ann Palliat Med
. 2023 Apr;
12(3):600-606.
PMID: 37038067
Background: Cancer patients often experience symptoms such as anorexia, anxiety and insomnia, which can impact their quality of life. Randomized placebo-controlled trials support prophylactic use of olanzapine for the prevention...
2.
Amenyogbe N, Dimitriu P, Cho P, Ruck C, Fortuno 3rd E, Cai B, et al.
J Immunol
. 2020 Oct;
205(10):2618-2628.
PMID: 33067377
In both high- and low-income countries, HIV-negative children born to HIV-positive mothers (HIV exposed, uninfected [HEU]) are more susceptible to severe infection than HIV-unexposed, uninfected (HUU) children, with altered innate...
3.
Smolen K, Ruck C, Fortuno 3rd E, Ho K, Dimitriu P, Mohn W, et al.
J Allergy Clin Immunol
. 2013 Dec;
133(3):818-26.e4.
PMID: 24290283
Background: Susceptibility to infection as well as response to vaccination varies among populations. To date, the underlying mechanisms responsible for these clinical observations have not been fully delineated. Because innate...
4.
Al-Dabbagh M, Lapphra K, Scheifele D, Halperin S, Langley J, Cho P, et al.
Clin Vaccine Immunol
. 2013 May;
20(8):1108-14.
PMID: 23697573
Oculorespiratory syndrome (ORS) is an infrequent adverse event following influenza vaccination. Its clinical presentation suggests that ORS is an immune-mediated phenomenon, but studies of symptomatic individuals have been few. This...
5.
Ali S, Hirschfeld A, Mayer M, Fortuno 3rd E, Corbett N, Kaplan M, et al.
J Immunol
. 2013 Mar;
190(8):3949-58.
PMID: 23487427
Respiratory diseases are the most frequent chronic illnesses in babies and children. Although a vigorous innate immune system is critical for maintaining lung health, a balanced response is essential to...
6.
Dias C, McDonald A, Sincan M, Rupps R, Markello T, Salvarinova R, et al.
Eur J Hum Genet
. 2013 Feb;
21(11):1232-9.
PMID: 23443029
Inflammation is an important contributor to pediatric and adult neurodegeneration. Understanding the genetic determinants of neuroinflammation provides valuable insight into disease mechanism. We characterize a disorder of recurrent immune-mediated neurodegeneration....
7.
Villa D, Gubbay J, Sutherland D, Laister R, McGeer A, Cooper C, et al.
Leuk Lymphoma
. 2012 Dec;
54(7):1387-95.
PMID: 23240909
This is a randomized trial evaluating the safety and immunogenicity of one or two doses of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies. Adults with a lymphoid...
8.
Hajjar A, Ernst R, Fortuno 3rd E, Brasfield A, Yam C, Newlon L, et al.
PLoS Pathog
. 2012 Oct;
8(10):e1002963.
PMID: 23071439
Although lipopolysaccharide (LPS) stimulation through the Toll-like receptor (TLR)-4/MD-2 receptor complex activates host defense against Gram-negative bacterial pathogens, how species-specific differences in LPS recognition impact host defense remains undefined. Herein,...
9.
Reikie B, Adams R, Ruck C, Ho K, Leligdowicz A, Pillay S, et al.
PLoS One
. 2012 Oct;
7(9):e44763.
PMID: 23028609
The first year of life represents a time of marked susceptibility to infections; this is particularly true for regions in sub-Saharan Africa. As innate immunity directs the adaptive immune response,...
10.
Smolen K, Gelinas L, Franzen L, Dobson S, Dawar M, Ogilvie G, et al.
Vaccine
. 2012 Apr;
30(24):3572-9.
PMID: 22469863
Vaccination is one of the most effective medical interventions. However, optimization of existing as well as design of new vaccines is still mostly conducted empirically; a rational approach to vaccine...